Skip to main content
Top

10-09-2024 | Obstructive Lung Diseases | News

ERS 2024

ABRA study positions benralizumab as new treatment for asthma, COPD exacerbations

Author: Dr. Shreeya Nanda

medwireNews: The combination of benralizumab plus standard corticosteroids is better than corticosteroids alone for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), indicate data presented at the ERS Congress 2024.

Related topics

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now
Video
SPONSORED

Targeting COPD with type 2 inflammation: emerging biologic landscape

1.5 European CME credits (ECMEC®s)

Watch an insightful session tailored for pulmonologists and healthcare professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies.

Sponsored by:
  • Sanofi
Developed by: Springer Healthcare
Watch now
Video